Skip to content

Weightloss induced changes of adipose tissue characteristics, in relation to atrial fibrillation.

Weightloss induced changes of adipose tissue characteristics, in relation to atrial fibrillation. - Weightloss AF

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44290
Enrollment
64
Registered
2017-12-20
Start date
2018-09-17
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eigenschappen van vetweefsel (dys)function adipose tissue fat tissue characteristics

Interventions

atrial fibrillation
bariatric surgery

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patient undergoing bariatric surgery (BMI above 35) Age above 40

Exclusion criteria

Exclusion criteria: taking 2 or more antihypertensiva taking metformine for diabetes heart diseases, for example myocardinfarct in past

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints * AT mass, distribution and ratios (EAT, PAT,VAT) * Circulating AT derived protein biomarkers, including: (1) inflammatory markers, (2) adipocytokines, (3) oxidative stress markers, (4) growth and remodelling markers, (5) markers representing AT metabolism. * Circulating AT derived miRNAs * Locally AT derived protein biomarkers, extracted from VAT. Markers similar to those in circulation. * Locally AT derived miRNAs extracted from VAT. * Anthropometric measurements: height, weight, BMI, waist-circumference, hip-waist ratio. * Occurrence/absence of AF by an approved 7 days rhythm monitoring system. * 1. Questionnaire about food and calorie intake: Diet journal for one week using an Internet application (Eetmeter, Stichting Voedingscentrum Nederland, The Hague, Netherlands). * 1. EPIC Norfolk Food Frequency Intake Questionnaire * 2. International Physical Activity Questionnaire.

Secondary

MeasureTime frame
Clinical data: data is gathered on the patients history and medication use and AF associated factors such as coronary artery disease, gender, age, hypertension, medication use and response, smoking, BMI, kidney function and laboratory parameters.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)